Asia Vets Holdings Statistics

Total Valuation

SGXC:5RE has a market cap or net worth of SGD 7.31 million. The enterprise value is -266,916.

Market Cap	7.31M
Enterprise Value	-266,916

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

SGXC:5RE has 146.15 million shares outstanding.

Current Share Class	146.15M
Shares Outstanding	146.15M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	28.63%
Owned by Institutions (%)	4.92%
Float	40.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.90
PB Ratio	0.46
P/TBV Ratio	0.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.14
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.42

Financial Position

The company has a current ratio of 10.45, with a Debt / Equity ratio of 0.03.

Current Ratio	10.45
Quick Ratio	10.24
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.82
Interest Coverage	-76.95

Financial Efficiency

Return on equity (ROE) is -11.72% and return on invested capital (ROIC) is -3.05%.

Return on Equity (ROE)	-11.72%
Return on Assets (ROA)	-2.95%
Return on Invested Capital (ROIC)	-3.05%
Return on Capital Employed (ROCE)	-5.21%
Revenue Per Employee	126,072
Profits Per Employee	-98,798
Employee Count	21
Asset Turnover	0.14
Inventory Turnover	19.76

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +42.86% in the last 52 weeks. The beta is 0.38, so SGXC:5RE's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	+42.86%
50-Day Moving Average	0.04
200-Day Moving Average	0.06
Relative Strength Index (RSI)	55.65
Average Volume (20 Days)	17,210

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SGXC:5RE had revenue of SGD 2.52 million and -1.98 million in losses. Loss per share was -0.01.

Revenue	2.52M
Gross Profit	693,850
Operating Income	-839,029
Pretax Income	-1.98M
Net Income	-1.98M
EBITDA	-780,165
EBIT	-839,029
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 8.10 million in cash and 527,084 in debt, giving a net cash position of 7.57 million or 0.05 per share.

Cash & Cash Equivalents	8.10M
Total Debt	527,084
Net Cash	7.57M
Net Cash Per Share	0.05
Equity (Book Value)	15.87M
Book Value Per Share	0.11
Working Capital	8.08M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -170,750 and capital expenditures -469,169, giving a free cash flow of -639,919.

Operating Cash Flow	-170,750
Capital Expenditures	-469,169
Free Cash Flow	-639,919
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 27.52%, with operating and profit margins of -33.28% and -78.37%.

Gross Margin	27.52%
Operating Margin	-33.28%
Pretax Margin	-78.37%
Profit Margin	-78.37%
EBITDA Margin	-30.94%
EBIT Margin	-33.28%
FCF Margin	n/a

Dividends & Yields

SGXC:5RE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-27.04%
FCF Yield	-8.76%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SGXC:5RE has an Altman Z-Score of 2.97 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.97
Piotroski F-Score	2